Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
4892 | 1706 | 29.7 | 81% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
118 | 3 | EPSTEIN BARR VIRUS//LYMPHOMA//HODGKINS DISEASE | 69002 |
567 | 2 | MALT LYMPHOMA//LYMPHOMA//PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA | 14422 |
4892 | 1 | EXTRANODAL NK T CELL LYMPHOMA//BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM//NK T CELL LYMPHOMA | 1706 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | EXTRANODAL NK T CELL LYMPHOMA | authKW | 946681 | 4% | 73% | 72 |
2 | BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM | authKW | 813494 | 3% | 91% | 50 |
3 | NK T CELL LYMPHOMA | authKW | 730311 | 4% | 61% | 67 |
4 | EXTRANODAL NATURAL KILLER T CELL LYMPHOMA | authKW | 613966 | 2% | 84% | 41 |
5 | CD56 | authKW | 535755 | 7% | 26% | 114 |
6 | NASAL TYPE | authKW | 527784 | 2% | 72% | 41 |
7 | NASAL LYMPHOMA | authKW | 517215 | 2% | 85% | 34 |
8 | LETHAL MIDLINE GRANULOMA | authKW | 417182 | 2% | 90% | 26 |
9 | NATURAL KILLER CELL LYMPHOMA | authKW | 369230 | 2% | 74% | 28 |
10 | BLASTIC NK CELL LYMPHOMA | authKW | 325398 | 1% | 91% | 20 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 13409 | 27% | 0% | 466 |
2 | Pathology | 8464 | 20% | 0% | 345 |
3 | Oncology | 6782 | 33% | 0% | 570 |
4 | Otorhinolaryngology | 3017 | 9% | 0% | 157 |
5 | Dermatology | 1469 | 8% | 0% | 128 |
6 | Medical Laboratory Technology | 488 | 3% | 0% | 52 |
7 | Radiology, Nuclear Medicine & Medical Imaging | 194 | 5% | 0% | 92 |
8 | Surgery | 86 | 6% | 0% | 105 |
9 | Dentistry, Oral Surgery & Medicine | 80 | 2% | 0% | 39 |
10 | Medicine, Research & Experimental | 75 | 4% | 0% | 63 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LYMPHOMA DIAG TREATMENT HENAN PROV | 53691 | 0% | 100% | 3 |
2 | HEMATOL ONCOLSTATE ONCOL SOUTH CHIN | 35794 | 0% | 100% | 2 |
3 | UOS RADIOTER IA ONCOEMATOL | 35794 | 0% | 100% | 2 |
4 | YONSEI CANC SEODAEMOON GU | 35794 | 0% | 100% | 2 |
5 | PATHOL C3 | 27863 | 1% | 17% | 9 |
6 | GRP ETUD IMMUNOL LEUCEMIES | 23861 | 0% | 67% | 2 |
7 | ABDOMEN CARCINOMA | 17897 | 0% | 100% | 1 |
8 | ADV BIOSCI UGA | 17897 | 0% | 100% | 1 |
9 | ANAT PATHOL SECTFDN POLICLIN | 17897 | 0% | 100% | 1 |
10 | ANAT PATHOLCYTOPATHOL UNIT | 17897 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LEUKEMIA & LYMPHOMA | 16950 | 5% | 1% | 85 |
2 | INTERNATIONAL JOURNAL OF HEMATOLOGY | 7927 | 2% | 1% | 41 |
3 | ANNALS OF HEMATOLOGY | 4947 | 2% | 1% | 32 |
4 | AMERICAN JOURNAL OF SURGICAL PATHOLOGY | 3961 | 2% | 1% | 37 |
5 | INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION | 3699 | 1% | 2% | 11 |
6 | HUMAN PATHOLOGY | 3042 | 2% | 0% | 37 |
7 | LEUKEMIA RESEARCH | 2618 | 2% | 0% | 30 |
8 | HISTOPATHOLOGY | 2130 | 2% | 0% | 26 |
9 | HEMATOLOGICAL ONCOLOGY | 2076 | 1% | 1% | 10 |
10 | CANCER | 1885 | 3% | 0% | 55 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | TSE, E , KWONG, YL , (2013) HOW I TREAT NK/T-CELL LYMPHOMAS.BLOOD. VOL. 121. ISSUE 25. P. 4997-5005 | 60 | 87% | 48 |
2 | TSE, E , KWONG, YL , (2016) DIAGNOSIS AND MANAGEMENT OF EXTRANODAL NK/T CELL LYMPHOMA NASAL TYPE.EXPERT REVIEW OF HEMATOLOGY. VOL. 9. ISSUE 9. P. 861 -871 | 66 | 88% | 0 |
3 | SUZUKI, R , (2014) PATHOGENESIS AND TREATMENT OF EXTRANODAL NATURAL KILLER/T-CELL LYMPHOMA.SEMINARS IN HEMATOLOGY. VOL. 51. ISSUE 1. P. 42-51 | 60 | 83% | 23 |
4 | AL-HAKEEM, DA , FEDELE, S , CARLOS, R , PORTER, S , (2007) EXTRANODAL NK/T-CELL LYMPHOMA, NASAL TYPE.ORAL ONCOLOGY. VOL. 43. ISSUE 1. P. 4-14 | 90 | 72% | 41 |
5 | LIANG, XY , GRAHAM, DK , (2008) NATURAL KILLER CELL NEOPLASMS.CANCER. VOL. 112. ISSUE 7. P. 1425 -1436 | 72 | 83% | 49 |
6 | YANG, Y , ZHU, Y , CAO, JZ , ZHANG, YJ , XU, LM , YUAN, ZY , WU, JX , WANG, W , WU, T , LU, B , ET AL (2015) RISK-ADAPTED THERAPY FOR EARLY-STAGE EXTRANODAL NASAL-TYPE NK/T-CELL LYMPHOMA: ANALYSIS FROM A MULTICENTER STUDY.BLOOD. VOL. 126. ISSUE 12. P. 1424 -1432 | 47 | 90% | 10 |
7 | PAGANO, L , VALENTINI, CG , GRAMMATICO, S , PULSONI, A , (2016) BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM: DIAGNOSTIC CRITERIA AND THERAPEUTICAL APPROACHES.BRITISH JOURNAL OF HAEMATOLOGY. VOL. 174. ISSUE 2. P. 188 -202 | 55 | 89% | 0 |
8 | RIAZ, W , ZHANG, L , HORNA, P , SOKOL, L , (2014) BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM: UPDATE ON MOLECULAR BIOLOGY, DIAGNOSIS, AND THERAPY.CANCER CONTROL. VOL. 21. ISSUE 4. P. 279 -289 | 51 | 89% | 10 |
9 | SANDRINI, J , TRUONG, C , LARIBI, K , DENIZON, N , BESANCON, A , FARHI, J , LEMAIRE, P , GHNAYA, H , DE MATERRE, AB , (2016) BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM: FROM ORIGIN OF THE CELL TO TARGETED THERAPIES.BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. VOL. 22. ISSUE 8. P. 1357 -1367 | 56 | 77% | 1 |
10 | RIET, FG , CANOVA, CH , GABARRE, J , BEN HASSINE, S , KOM, LK , MAZERON, JJ , FEUVRET, L , (2014) RADIATION THERAPY OF SINONASAL NATURAL KILLER/T-CELL LYMPHOMA.CANCER RADIOTHERAPIE. VOL. 18. ISSUE 2. P. 147-153 | 52 | 90% | 2 |
Classes with closest relation at Level 1 |